Can-Hui Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Can-Hui Sun has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Ren Mao
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
3 shared publications - Xuehua Li
Department of Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
3 shared publications Li Huang
Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
2 shared publicationsLu Yu
Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China
2 shared publications- Mengchen Zhang
First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
2 shared publications - Ping Xu
First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 16 March 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 69
Development and evaluation of a predictive model based on multi-frequency magnetic resonance elastography for high-risk esophagogastric varices in patients with cirrhotic portal hypertension
Objectives: This study aimed to assess the severity of esophagogastric varices (EGV) in patients with cirrhotic portal hypertension by measuring liver and spleen stiffness with multi-frequency magnetic resonance elastography (MRE), and to develop a predictive model for identifying high-risk EGV. Materials and methods: Fifty-four patients with cirrhosis and portal hypertension were enrolled. Clinical and imaging parameters were analyzed, and Bland–Altman analysis and intraclass correlation coefficient (ICCs) evaluated interobserver agreement. Independent-sample t -tests were used to analyze the differences in liver and spleen stiffness between high-risk and low-risk groups. The correlations between variables and the endoscopic EGV severity were analyzed by Spearman’s correlation analysis and univariate logistic analysis. Multivariate logistic regression identified independent predictors, and receiver operating characteristic (ROC) and decision curve analyses assessed model performance and clinical utility. Bootstrap resampling and sensitivity analyses validated model robustness. Results: Bland–Altman analysis and ICC analysis showed high consistency. There were significant differences in liver and spleen stiffness between low-risk and high-risk patients. Platelet count and plateletcrit were negatively correlated with variceal severity, whereas bilirubin, INR, liver/spleen stiffness, spleen volume, and portal/splenic vein diameters showed positive correlations. Multivariate analysis identified spleen stiffness and portal vein diameter as independent predictors. The predictive model y = −17.50 + 2.77× spleen stiffness +0.57× portal vein diameter demonstrated superior predictive performance compared to individual indicators. Bootstrap resampling and sensitivity analyses demonstrated the robustness and stability of the model’s predictive performance. Conclusion: The model effectively identifies high-risk EGV, highlighting the potential of noninvasive MRE-based assessment to guide early intervention and reduce variceal bleeding risk. Critical relevance statement: The predictive model based on multi-frequency MRE and MRI parameters (spleen stiffness + portal vein diameter) can effectively screen out high-risk EGV, which is helpful for guiding timely clinical intervention, so as to reduce the risk of EGV bleeding in these patients, and improve their prognoses. Key Points: Multifrequency magnetic resonance elastography (MRE) can indicate the stiffness of the liver and spleen. The splenic stiffness is a reliable predictor of high-risk EGV. The predictive model can effectively screen out high-risk EGV. Graphical
- 16 March 2026
- Published by Springer Nature in Insights into Imaging
- Vol. 17 (1) , 69
Open AccessDevelopment and evaluation of a predictive model based on multi-frequency magnetic resonance elastography for high-risk esophagogastric varices in patients with cirrhotic portal hypertension
Objectives: This study aimed to assess the severity of esophagogastric varices (EGV) in patients with cirrhotic portal hypertension by measuring liver and spleen stiffness with multi-frequency magnetic resonance elastography (MRE), and to develop a predictive model for identifying high-risk EGV. Materials and methods: Fifty-four patients with cirrhosis and portal hypertension were enrolled. Clinical and imaging parameters were analyzed, and Bland–Altman analysis and intraclass correlation coefficient (ICCs) evaluated interobserver agreement. Independent-sample t -tests were used to analyze the differences in liver and spleen stiffness between high-risk and low-risk groups. The correlations between variables and the endoscopic EGV severity were analyzed by Spearman’s correlation analysis and univariate logistic analysis. Multivariate logistic regression identified independent predictors, and receiver operating characteristic (ROC) and decision curve analyses assessed model performance and clinical utility. Bootstrap resampling and sensitivity analyses validated model robustness. Results: Bland–Altman analysis and ICC analysis showed high consistency. There were significant differences in liver and spleen stiffness between low-risk and high-risk patients. Platelet count and plateletcrit were negatively correlated with variceal severity, whereas bilirubin, INR, liver/spleen stiffness, spleen volume, and portal/splenic vein diameters showed positive correlations. Multivariate analysis identified spleen stiffness and portal vein diameter as independent predictors. The predictive model y = −17.50 + 2.77× spleen stiffness +0.57× portal vein diameter demonstrated superior predictive performance compared to individual indicators. Bootstrap resampling and sensitivity analyses demonstrated the robustness and stability of the model’s predictive performance. Conclusion: The model effectively identifies high-risk EGV, highlighting the potential of noninvasive MRE-based assessment to guide early intervention and reduce variceal bleeding risk. Critical relevance statement: The predictive model based on multi-frequency MRE and MRI parameters (spleen stiffness + portal vein diameter) can effectively screen out high-risk EGV, which is helpful for guiding timely clinical intervention, so as to reduce the risk of EGV bleeding in these patients, and improve their prognoses. Key Points: Multifrequency magnetic resonance elastography (MRE) can indicate the stiffness of the liver and spleen. The splenic stiffness is a reliable predictor of high-risk EGV. The predictive model can effectively screen out high-risk EGV. Graphical
- Open Access
- 1 July 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-9
Non-invasive assessment of liver function in cirrhosis using iodine density difference between the portal vein and hepatic vein on spectral CT: correlation with Child-Pugh grades
To explore the feasibility and clinical significance of assessing liver function damage in patients with post-hepatitis cirrhosis using spectral CT by measuring the iodine density difference and CT value difference between the portal vein and hepatic vein. A study was conducted involving 65 patients with post-hepatitis cirrhosis (30 with Child-Pugh grade A, 28 with grade B, and 7 with grade C) and 82 healthy controls. All underwent dual-phase enhanced spectral CT scans of the upper abdomen. Post-processing with IntelliSpace Portal software yielded iodine density (ID), 45 keV virtual monoenergetic (VMI), and conventional CT (HU) images. The mean iodine densities of the portal vein (IDP) and hepatic vein (IDV) were measured, and the difference in ID (IDd−value), VMI (VMId−value), and HU (HUd−value) between the portal vein and hepatic vein was calculated. These values were compared between the control group and different Child-Pugh grades of cirrhosis, as well as between the compensated cirrhosis group (Child-Pugh grade A) and the decompensated cirrhosis group (grade B/C). The ability to diagnose decompensated cirrhosis was evaluated by plotting ROC curves. The IDd−value, VMId−value, and HU d−value were significantly higher in the cirrhosis group compared to the control group and were also higher in the grade B/C group compared to the grade A group (all p<0.05). Among all patients with cirrhosis, the AUROC values for diagnosing grade B/C using IDd−value, VMId−value, HUd−value, NIDd−value, NVMI d−value, and NHUd−value were 0.774, 0.798, 0.736, 0.775, 0.774, and 0.757, respectively (all p < 0.05). The iodine density difference (IDd−value) and CT value difference (VMId−value and HU d−value) between the portal vein and hepatic vein, as measured by spectral CT, demonstrate a significant positive correlation with the Child-Pugh classification of liver function in cirrhotic patients. These quantitative parameters provide a simple and non-invasive approach for assessing liver function in cirrhotic patients. Not applicable.
- 1 July 2025
- Published by Springer Nature in BMC Medical Imaging
- Vol. 25 (1) , 1-9
Open AccessNon-invasive assessment of liver function in cirrhosis using iodine density difference between the portal vein and hepatic vein on spectral CT: correlation with Child-Pugh grades
To explore the feasibility and clinical significance of assessing liver function damage in patients with post-hepatitis cirrhosis using spectral CT by measuring the iodine density difference and CT value difference between the portal vein and hepatic vein. A study was conducted involving 65 patients with post-hepatitis cirrhosis (30 with Child-Pugh grade A, 28 with grade B, and 7 with grade C) and 82 healthy controls. All underwent dual-phase enhanced spectral CT scans of the upper abdomen. Post-processing with IntelliSpace Portal software yielded iodine density (ID), 45 keV virtual monoenergetic (VMI), and conventional CT (HU) images. The mean iodine densities of the portal vein (IDP) and hepatic vein (IDV) were measured, and the difference in ID (IDd−value), VMI (VMId−value), and HU (HUd−value) between the portal vein and hepatic vein was calculated. These values were compared between the control group and different Child-Pugh grades of cirrhosis, as well as between the compensated cirrhosis group (Child-Pugh grade A) and the decompensated cirrhosis group (grade B/C). The ability to diagnose decompensated cirrhosis was evaluated by plotting ROC curves. The IDd−value, VMId−value, and HU d−value were significantly higher in the cirrhosis group compared to the control group and were also higher in the grade B/C group compared to the grade A group (all p<0.05). Among all patients with cirrhosis, the AUROC values for diagnosing grade B/C using IDd−value, VMId−value, HUd−value, NIDd−value, NVMI d−value, and NHUd−value were 0.774, 0.798, 0.736, 0.775, 0.774, and 0.757, respectively (all p < 0.05). The iodine density difference (IDd−value) and CT value difference (VMId−value and HU d−value) between the portal vein and hepatic vein, as measured by spectral CT, demonstrate a significant positive correlation with the Child-Pugh classification of liver function in cirrhotic patients. These quantitative parameters provide a simple and non-invasive approach for assessing liver function in cirrhotic patients. Not applicable.
- Open Access
- 4 December 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (6) , 2781
Correction to: Deep learning-based reconstruction improves the image quality of low-dose CT enterography in patients with inflammatory bowel disease
- 4 December 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (6) , 2781
Open AccessCorrection to: Deep learning-based reconstruction improves the image quality of low-dose CT enterography in patients with inflammatory bowel disease
- 21 September 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (9) , 3907-3916
Deep learning-based reconstruction improves the image quality of low-dose CT enterography in patients with inflammatory bowel disease
Purpose Lifelong re-examination of CT enterography (CTE) in patients with inflammatory bowel disease (IBD) may be necessary, and reducing radiation exposure during CT examinations is crucial. We investigated the potential application of deep learning reconstruction (DLR) in CTE to reduce radiation dose and improve image quality in IBD. Methods Thirty-six patients with known or suspected IBD were prospectively recruited to the low-dose CTE (LDCTE) group, while forty patients were retrospectively selected from previous clinical standard-dose CTE (STDCTE) scans as controls. STDCTE images were reconstructed with hybrid-IR (adaptive iterative dose reduction 3-dimensional [AIDR3D], standard setting); LDCTE images were reconstructed with AIDR3D and DLR (Advanced Intelligence ClearIQ Engine [AiCE], Body mild/standard/strong, Sharp Body mild/standard/strong setting). The effective radiation dose (ED), image noise, signal-to-noise ratio (SNR), overall image quality, subjective image noise, and diagnostic effectiveness were compared between the LDCTE and STDCTE groups. Results Compared with STDCTE, the ED of LDCTE was lower by 54.1% (p<0.001). Compared with STDCTE-AIDR3D, LDCTE-AIDR3D reconstruction objective image noise and SNR were greater (p<0.05), the subjective overall image quality was lower (p<0.05), and the diagnostic efficiency was lower (AUC=0.52, p<0.05). The SNRs of reconstructedimages of LDCTE-AiCE Body Strong and LDCTE-AiCE Body Sharp standard/strong groups were greater than that of STDCTE-AIDR3D group (all p<0.05), and the diagnostic performance was better than or comparable to that of STDCTE; the AUCs were 0.83, 0.76 and 0.76, respectively Conclusion Compared with STDCTE with AIDR3D, LDCTE with DLR effectively reduced the radiation dose and improve image quality in IBD patients.
- 21 September 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (9) , 3907-3916
Deep learning-based reconstruction improves the image quality of low-dose CT enterography in patients with inflammatory bowel disease
Purpose Lifelong re-examination of CT enterography (CTE) in patients with inflammatory bowel disease (IBD) may be necessary, and reducing radiation exposure during CT examinations is crucial. We investigated the potential application of deep learning reconstruction (DLR) in CTE to reduce radiation dose and improve image quality in IBD. Methods Thirty-six patients with known or suspected IBD were prospectively recruited to the low-dose CTE (LDCTE) group, while forty patients were retrospectively selected from previous clinical standard-dose CTE (STDCTE) scans as controls. STDCTE images were reconstructed with hybrid-IR (adaptive iterative dose reduction 3-dimensional [AIDR3D], standard setting); LDCTE images were reconstructed with AIDR3D and DLR (Advanced Intelligence ClearIQ Engine [AiCE], Body mild/standard/strong, Sharp Body mild/standard/strong setting). The effective radiation dose (ED), image noise, signal-to-noise ratio (SNR), overall image quality, subjective image noise, and diagnostic effectiveness were compared between the LDCTE and STDCTE groups. Results Compared with STDCTE, the ED of LDCTE was lower by 54.1% (p<0.001). Compared with STDCTE-AIDR3D, LDCTE-AIDR3D reconstruction objective image noise and SNR were greater (p<0.05), the subjective overall image quality was lower (p<0.05), and the diagnostic efficiency was lower (AUC=0.52, p<0.05). The SNRs of reconstructedimages of LDCTE-AiCE Body Strong and LDCTE-AiCE Body Sharp standard/strong groups were greater than that of STDCTE-AIDR3D group (all p<0.05), and the diagnostic performance was better than or comparable to that of STDCTE; the AUCs were 0.83, 0.76 and 0.76, respectively Conclusion Compared with STDCTE with AIDR3D, LDCTE with DLR effectively reduced the radiation dose and improve image quality in IBD patients.
- Open Access
- 28 August 2021
- Published by MDPI AG in Biosensors
- Vol. 11 (9) , 302
Native T1 Mapping and Magnetization Transfer Imaging in Grading Bowel Fibrosis in Crohn’s Disease: A Comparative Animal Study
In this study, we investigated the utility of native T1 mapping in differentiating between various grades of fibrosis and compared its diagnostic accuracy to magnetization transfer imaging (MTI) in a rat model of CD. Bowel specimens (64) from 46 CD model rats undergoing native T1 mapping and MTI were enrolled. The longitudinal relaxation time (T1 value) and normalized magnetization transfer ratio (MTR) were compared between none-to-mild and moderate-to-severe fibrotic bowel walls confirmed by pathological assessments. The results showed that the correlation between the T1 value and fibrosis (r = 0.438, p < 0.001) was lower than that between the normalized MTR and fibrosis (r = 0.623, p < 0.001). Overall, the T1 values (t = −3.066, p = 0.004) and normalized MTRs (z = 0.081, p < 0.001) in none-to-mild fibrotic bowel walls were lower than those in moderate-to-severe fibrotic bowel walls. The area under the curve (AUC) of the T1 value (AUC = 0.716, p = 0.004) was significantly lower than that of the normalized MTR (AUC = 0.881, p < 0.001) in differentiating moderate-to-severe fibrosis from none-to-mild fibrosis (z = −2.037, p = 0.042). Our results support the view that the T1 value could be a promising imaging biomarker in grading the fibrosis severity of CD. However, the diagnostic performance of native T1 mapping was not superior to MTI.
- 28 August 2021
- Published by MDPI AG in Biosensors
- Vol. 11 (9) , 302
Open AccessNative T1 Mapping and Magnetization Transfer Imaging in Grading Bowel Fibrosis in Crohn’s Disease: A Comparative Animal Study
In this study, we investigated the utility of native T1 mapping in differentiating between various grades of fibrosis and compared its diagnostic accuracy to magnetization transfer imaging (MTI) in a rat model of CD. Bowel specimens (64) from 46 CD model rats undergoing native T1 mapping and MTI were enrolled. The longitudinal relaxation time (T1 value) and normalized magnetization transfer ratio (MTR) were compared between none-to-mild and moderate-to-severe fibrotic bowel walls confirmed by pathological assessments. The results showed that the correlation between the T1 value and fibrosis (r = 0.438, p < 0.001) was lower than that between the normalized MTR and fibrosis (r = 0.623, p < 0.001). Overall, the T1 values (t = −3.066, p = 0.004) and normalized MTRs (z = 0.081, p < 0.001) in none-to-mild fibrotic bowel walls were lower than those in moderate-to-severe fibrotic bowel walls. The area under the curve (AUC) of the T1 value (AUC = 0.716, p = 0.004) was significantly lower than that of the normalized MTR (AUC = 0.881, p < 0.001) in differentiating moderate-to-severe fibrosis from none-to-mild fibrosis (z = −2.037, p = 0.042). Our results support the view that the T1 value could be a promising imaging biomarker in grading the fibrosis severity of CD. However, the diagnostic performance of native T1 mapping was not superior to MTI.
- 13 March 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (7) , 3075-3085
A CT-based nomogram for predicting the malignant potential of primary gastric gastrointestinal stromal tumors preoperatively
Purpose To develop and validate a computerized tomography (CT)-based nomogram for predicting the malignant potential of primary gastric gastrointestinal stromal tumors (GISTs). Methods The primary and validation cohorts consisted of 167 and 39 patients (single center, different time periods) with histologically confirmed primary gastric GISTs. Clinical data and preoperative CT images were reviewed. The association of CT characteristics with malignant potential was analyzed using univariate and stepwise logistic regression analyses. A nomogram based on significant CT findings was developed for predicting malignant potential. The predictive accuracy of the nomogram was determined by the concordance index (C-index) and calibration curves. External validation was performed with the validation cohort. Results CT imaging features including tumor size, tumor location, tumor necrosis, growth pattern, ulceration, enlarged vessels feeding or draining the mass (EVFDM), tumor contour, mesenteric fat infiltration, and direct organ invasion showed significant differences between the low- and high-grade malignant potential groups in univariate analysis (P < 0.05). Only tumor size (> 5 cm vs ≤ 5 cm), location (cardiac/pericardial region vs other), EVFDM, and mesenteric fat infiltration (present vs absent) were significantly associated with high malignant potential in multivariate logistic regression analysis. Incorporating these four independent factors into the nomogram model achieved good C-indexes of 0.946 (95% confidence interval [CI] 0.899–0.975) and 0.952 (95% CI 0.913–0.977) in the primary and validation cohorts, respectively. The cutoff point was 0.33, with sensitivity, specificity, and diagnostic accuracy of 0.865, 0.915, and 0.780, respectively. Discussion Primary gastric GISTs originating in the cardiac/pericardial region appear to be associated with higher malignant potential. The nomogram consisting of CT features, including size, location, EVFDM, and mesenteric fat infiltration, could be used to accurately predict the high malignant potential of primary gastric GISTs.
- 13 March 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (7) , 3075-3085
A CT-based nomogram for predicting the malignant potential of primary gastric gastrointestinal stromal tumors preoperatively
Purpose To develop and validate a computerized tomography (CT)-based nomogram for predicting the malignant potential of primary gastric gastrointestinal stromal tumors (GISTs). Methods The primary and validation cohorts consisted of 167 and 39 patients (single center, different time periods) with histologically confirmed primary gastric GISTs. Clinical data and preoperative CT images were reviewed. The association of CT characteristics with malignant potential was analyzed using univariate and stepwise logistic regression analyses. A nomogram based on significant CT findings was developed for predicting malignant potential. The predictive accuracy of the nomogram was determined by the concordance index (C-index) and calibration curves. External validation was performed with the validation cohort. Results CT imaging features including tumor size, tumor location, tumor necrosis, growth pattern, ulceration, enlarged vessels feeding or draining the mass (EVFDM), tumor contour, mesenteric fat infiltration, and direct organ invasion showed significant differences between the low- and high-grade malignant potential groups in univariate analysis (P < 0.05). Only tumor size (> 5 cm vs ≤ 5 cm), location (cardiac/pericardial region vs other), EVFDM, and mesenteric fat infiltration (present vs absent) were significantly associated with high malignant potential in multivariate logistic regression analysis. Incorporating these four independent factors into the nomogram model achieved good C-indexes of 0.946 (95% confidence interval [CI] 0.899–0.975) and 0.952 (95% CI 0.913–0.977) in the primary and validation cohorts, respectively. The cutoff point was 0.33, with sensitivity, specificity, and diagnostic accuracy of 0.865, 0.915, and 0.780, respectively. Discussion Primary gastric GISTs originating in the cardiac/pericardial region appear to be associated with higher malignant potential. The nomogram consisting of CT features, including size, location, EVFDM, and mesenteric fat infiltration, could be used to accurately predict the high malignant potential of primary gastric GISTs.
- 1 March 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (7) , 3149-3158
Hepatic mosaic enhancement pattern correlates with increased inflammatory activity and adverse therapeutic outcomes in patients with Crohn’s disease
Purpose This study aimed to evaluate the role of hepatic mosaic enhancement pattern (HMEP) on computed tomography images in the disease activity and therapeutic outcome of Crohn’s Disease (CD). Methods Twenty-five CD patients with HMEP comprised the HMEP group, and 25 CD patients without HMEP, who had a similar onset age, sex, and disease course with those in the HMEP group, comprised the non-HMEP group. No underlying liver/biliary disease was observed in any of the patients. Clinical characteristics, laboratory test results, Lémann index, and CD endoscopic index of severity (CDEIS) were compared between the groups using the Student t-, Mann–Whitney U, Chi square, or Fisher’s exact tests. Patients received top-down, step-up, or traditional treatment during the follow-up period. After the 1-year follow-up, therapeutic outcomes (active inflammation [CDEIS > 3.5 if the endoscopic data were available, or C-reactive protein level > 5 mg/L if the endoscopic data were unavailable] or remission) were evaluated. Results The occurrence rate of fistulas/abscesses was higher in the HMEP group (84%, 21/25) than in the non-HMEP group (48%, 12/25) with no statistical significance (P = 0.056). The HMEP group showed a higher C-reactive protein level (P = 0.001), erythrocyte sedimentation rate (P = 0.013), and blood platelet count (P = 0.005). There was no significant difference in therapeutic strategies between the groups (P = 0.509). The HMEP group showed a significantly lower remission ratio after anti-inflammatory treatment than the non-HMEP group (P = 0.045). Conclusions HMEP was correlated with increased inflammatory activity and adverse therapeutic outcomes in CD. This finding provided insights regarding novel markers of CD diagnosis and treatment.
- 1 March 2021
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (7) , 3149-3158
Hepatic mosaic enhancement pattern correlates with increased inflammatory activity and adverse therapeutic outcomes in patients with Crohn’s disease
Purpose This study aimed to evaluate the role of hepatic mosaic enhancement pattern (HMEP) on computed tomography images in the disease activity and therapeutic outcome of Crohn’s Disease (CD). Methods Twenty-five CD patients with HMEP comprised the HMEP group, and 25 CD patients without HMEP, who had a similar onset age, sex, and disease course with those in the HMEP group, comprised the non-HMEP group. No underlying liver/biliary disease was observed in any of the patients. Clinical characteristics, laboratory test results, Lémann index, and CD endoscopic index of severity (CDEIS) were compared between the groups using the Student t-, Mann–Whitney U, Chi square, or Fisher’s exact tests. Patients received top-down, step-up, or traditional treatment during the follow-up period. After the 1-year follow-up, therapeutic outcomes (active inflammation [CDEIS > 3.5 if the endoscopic data were available, or C-reactive protein level > 5 mg/L if the endoscopic data were unavailable] or remission) were evaluated. Results The occurrence rate of fistulas/abscesses was higher in the HMEP group (84%, 21/25) than in the non-HMEP group (48%, 12/25) with no statistical significance (P = 0.056). The HMEP group showed a higher C-reactive protein level (P = 0.001), erythrocyte sedimentation rate (P = 0.013), and blood platelet count (P = 0.005). There was no significant difference in therapeutic strategies between the groups (P = 0.509). The HMEP group showed a significantly lower remission ratio after anti-inflammatory treatment than the non-HMEP group (P = 0.045). Conclusions HMEP was correlated with increased inflammatory activity and adverse therapeutic outcomes in CD. This finding provided insights regarding novel markers of CD diagnosis and treatment.